Array BioPharma to price public offering of stock with greenshoe

Jefferies, Leerink Swann and Stifel Nicolaus Weisel help raise funds

By Devika Patel

Knoxville, Tenn., Feb. 8 - Array BioPharma Inc. will price a public offering of common stock, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission. The deal will have a 30-day greenshoe.

Jefferies and Leerink Swann are the joint bookrunning managers; Stifel Nicolaus Weisel is the co-manager.

Proceeds will be used for research and development efforts, including clinical trials, and general corporate purposes, including working capital.

Array BioPharma is a biopharmaceutical company based in Boulder, Colo., that develops and commercializes small molecule drugs with a focus on cancer and inflammatory diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.